Academic publisher SAGE has announced that it has extended its suite of Therapeutic Advances journals with the launch of two new titles - Therapeutic Advances in Drug Safety and Therapeutic Advances in Hematology.
Therapeutic Advances in Drug Safety covers novel and controversial aspects pertaining to the safe use of drugs in different age and ethnic patient groups, drug safety, therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.
Therapeutic Advances in Hematology is for professionals concerned with research and practice of hematology. The journal seeks to be a forum for publishing original research and reviews in this area including research across all areas of hematology, including all of the malignant myeloid and lymphoid disorders (leukemia, myeloproliferative disorders, myelodysplasia, myeloma, lymphoma), red cell and platelet disorders, including transfusion medicine and clotting disorders, and any other relevant topic in the field.
International in scope, both the journals will follow the successful format of the existing nine Therapeutic Advances titles, offering rapid peer review and publication, with manuscripts published online within seven weeks of acceptance. Each journal will publish six issues per year and will be freely available on the SAGE Journals Online platform for the first three years of publication.
Search for more Therapeutics related academic Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
